No Data
74 S&P 500 Stocks That Can Beat the Cash Yield - BofA
Barclays Adjusts Price Target on CVS Health to $63 From $65
E.l.f. Not Doing Enough Progress With Retailers Beyond Target -- Market Talk
HSBC Adjusts Price Target on CVS Health to $61 From $62
Analysts' Opinions Are Mixed on These Healthcare Stocks: CVS Health (CVS), Insulet (PODD) and Artivion (AORT)
CVS Health (CVS) Receives a Rating Update From a Top Analyst